Ads
related to: bd sterile needle
Search results
Results From The WOW.Com Content Network
The company was founded in 1897 in New York City by Maxwell Becton and Fairleigh S. Dickinson.It later moved its headquarters to New Jersey. In 2004, BD agreed to pay out US$100 million to settle allegations from competitor Retractable Technologies that it had engaged in anti-competitive behavior to prevent the distribution of Retractable's syringes, which are designed to prevent needlestick ...
The hypodermic needle significantly reduces contamination during inoculation of a sterile substrate. The hypodermic needle reduces contamination for two reasons: First, its surface is extremely smooth, which prevents airborne pathogens from becoming trapped between irregularities on the needle's surface, which would subsequently be transferred ...
The Vacutainer needle is double-ended: the inner end is encased in a thin rubber coating that prevents blood from leaking out if the Vacutainer tubes are changed during a multi-draw, and the outer end which is inserted into the vein. When the needle is screwed into the translucent plastic needle holder, the coated end is inside the holder.
Disposable syringe with needle, with parts labelled: plunger, barrel, needle adaptor, needle hub, needle bevel, needle shaft According to the World Health Organization, about 90% of the medical syringes are used to administer drugs, 5% for vaccinations and 5% for other uses such as blood transfusions.
After buying out Randall, Becton and Dickerson created a partnership to sell medical thermometers and syringes, in 1897. [1] [2] [4] Later, the company also produced hypodermic needles and syringes to inject insulin. [4] The company incorporated as Becton, Dickinson & Company in 1906 and built a manufacturing plant in East Rutherford, New Jersey.
Microneedles (MNs) consist of micro-sized needles arrays that are made of various materials exhibiting different characteristics and are suitable in the synthesis of different types of MNs. The selection of materials for formation of MNs greatly depends on the strength of skin penetration, manufacturing method, and rate of drug release.